Started and built multiple companies, served in C-level and top management roles in Europe and North America
of peer-reviewed publications, and
are inventors on
dozens of patents
Dalriada’s TURN-KEY Drug Discovery model is fundamentally built on the unique expertise brought under one roof that allows for most rapid value building in today’s pharmaceutical industry.
Our team equally understands science and business to allow for a seamless collaborative work with any partner.
Worked in leadership
R&D and business roles
in Big Pharma, including GSK, Boehringer Ingelheim, Merck, Vertex and Sanofi, advancing multiple compounds to preclinical development, clinical trials, and to market
Headed programs and investments that were sold
in > $1 B deals to big Pharma
We rapidly source project-specific
through our network
Successfully raised VC capital, and led investments into multiple European and North American companies that were sold or went public
Multidisciplinary team of medicinal and bioanalytical chemists, biologists and biochemists work in perfectly coordinated teams. Scientific team trained on patent law by a top US law firm. A perfect blend of industry experts and fresh out of academia innovators
and spearheaded multiple >$100 M initiative in pharma, industry,
Whether you are a specialist in synthetic methodology or a generalist in drug discovery, at Dalriada you will get a unique opportunity to immerse yourself in an exciting career of drug discovery and innovate alongside start-ups and multi-billion dollar companies.
We are equally open to interviewing top-notch industry experts and recent graduates who are passionate about drug discovery and the pharmaceutical industry.